학술논문
TP53 DNA binding domain mutational status and rituximab-based treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification
Document Type
article
Author
Source
Haematologica, Vol 999, Iss 1 (2024)
Subject
Language
English
ISSN
0390-6078
1592-8721
1592-8721
Abstract
Not available.